CDEK
← All drugs Report issue

itropride

Small moleculeexperimental

Clinical trial activity

23 trials · 20 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
13
Phase 3
10
Phase 4
3

Earliest trial started Dec 1, 2000 (NCT00272103)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC
Mol. weight
358.44 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ganaton
  • itopride
  • itopride
  • itopride
  • itopride
  • itopride
  • itopride
  • itopride
  • itopride hcl
  • itopride hydrochloride
  • itopride hydrochloride
  • itopride hydrochloride
  • itopride hydrochloride
  • itopride hydrochloride
  • itropride
  • n-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide
  • n-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide
  • n-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide hydrochloride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06217393Phase 3Feb 28, 2024Abbott
NCT05966025Phase 2Dec 28, 2023Beni Suef University, October 6 University
NCT05134584Phase 4Aug 1, 2021Jiao Tong University
NCT04104867N/ASep 16, 2019Mahidol University
NCT04161768Phase 3Dec 1, 2018Tanta University
NCT03698292N/AOct 31, 2018Ain Shams University, Future University in Egypt
NCT04697641N/ASep 1, 2017Sir Ganga Ram Hospital
NCT04464369Phase 4Sep 30, 2013Katholieke Universiteit Leuven
NCT04647955Phase 4Feb 22, 2013Katholieke Universiteit Leuven
NCT01513096Phase 3Nov 1, 2011Inje University
NCT01513811Phase 2Feb 1, 2010Jiao Tong University
NCT01226134N/AFeb 1, 2009Aga Khan University
NCT01027260Phase 2Jun 1, 2008Abbott
NCT00599677N/ANov 1, 2007Chengdu University of Traditional Chinese Medicines
NCT00382577Phase 3Oct 1, 2006Forest Laboratories, The Oklahoma Foundation for Digestive Research
NCT00308399Phase 2/Phase 3 (Phase 3)Nov 1, 2005Axcan, Mayo Clinic
NCT00370110Phase 1/Phase 2 (Phase 2)Aug 1, 2005Forest Laboratories, Mayo Clinic
NCT00370084Phase 1/Phase 2 (Phase 2)Mar 1, 2005Forest Laboratories, University of Adelaide
NCT00112203Phase 3Nov 1, 2004Forest Laboratories, Katholieke Universiteit Leuven
NCT00110968Phase 3Sep 1, 2004Forest Laboratories, Mayo Clinic
Showing 20 of 23 trials
Page 1 / 2

Organizations

Research & Development (20)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Forest LaboratoriesFor profit7722004
Katholieke Universiteit LeuvenAcademic/Hospital4222004
Mayo ClinicAcademic/Hospital4122004
AbbottFor profit2222008
Jiao Tong UniversityAcademic/Hospital2222010
University of AdelaideAcademic/Hospital2122000
Aga Khan UniversityAcademic/Hospital1112009
Ain Shams UniversityAcademic/Hospital1112018
AxcanFor profit1012005
Beni Suef UniversityAcademic/Hospital1012023
Chengdu University of Traditional Chinese MedicinesAcademic/Hospital1112007
Future University in EgyptAcademic/Hospital1012018
Inje UniversityAcademic/Hospital1112011
KnollFor profit1012000
Mahidol UniversityAcademic/Hospital1112019
October 6 UniversityAcademic/Hospital1112023
Sir Ganga Ram HospitalAcademic/Hospital1112017
Tanta UniversityAcademic/Hospital1112018
The Oklahoma Foundation for Digestive ResearchAcademic/Hospital1012006
University of Duisburg-EssenAcademic/Hospital1012000
20 organizations
Page 1 / 1